ROPES WEALTH ADVISORS LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
ROPES WEALTH ADVISORS LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2020$29,000
+20.8%
2490.0%0.00%
-20.0%
Q3 2020$24,000
-22.6%
2490.0%0.01%
-16.7%
Q2 2020$31,000
+40.9%
2490.0%0.01%0.0%
Q1 2020$22,000
-15.4%
2490.0%0.01%0.0%
Q4 2019$26,000
-10.3%
2490.0%0.01%0.0%
Q3 2019$29,000
-19.4%
249
+19.1%
0.01%
-25.0%
Q2 2019$36,000
+2.9%
2090.0%0.01%
-11.1%
Q1 2019$35,000
+75.0%
2090.0%0.01%
+50.0%
Q4 2018$20,000
+66.7%
209
+202.9%
0.01%
+100.0%
Q3 2018$12,000690.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders